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1. Introduction 
An International Congress of Radiation Research 
convenes every 4 years. The 10th such congress was 
held in the German city of Wlrzburg, between Au- 
gust 27 and September 1, 1995. 
This meeting was especially notable, for both 
historical and scientific reasons. It was aptly held in 
the city where 100 years previously, one of the 
seminal scientific discoveries was made by Wilhelm 
Conrad Rontgen, the discovery of X-rays. From the 
perspective of modem radiation biology research, a 
major new trend was evident in the work presented 
at this meeting: the increasing contribution and power 
of molecular genetic approaches in addressing funda- 
mental questions in radiobiology, for example, the 
genetic events which determine the sensitivity of 
cells to ionizing radiation. It is clear that great strides 
have been made in this area since the last Intema- 
tional Congress of Radiation Research in Toronto, 
Canada, in 1991. This communication emphasises 
and attempts to present an overview of some of the 
ways in which molecular biology is contributing to, 
and influencing radiation research, as viewed through 
the ‘snapshot’ of this major radiation research 
congress. The report is selective, focussing on major 
* Corresponding author. 
themes arising from the Congress lectures, symposia 
and workshops attended by the authors. We believe 
it reflects the current status of this field and illus- 
trates some emerging trends. 
We make no attempt to be comprehensive, as we 
could not hope to do justice to even the biology 
contributions among the 128 1 scientific contributions 
at this congress, spanning the spectrum of radiation 
research. For this, the reader is referred to the pub- 
lished and upcoming congress proceedings. Because 
references are not included, the potential risks of 
misquoting dictate that only general concepts are 
presented. The authors accept responsibility for any 
errors of reporting or omisssion. 
2. DNA repair genes and molecular mechanisms 
of ionizing radiation-induced DNA damage repair 
A. Lehmann (University of Sussex, UK) dis- 
cussed methods used to identify and isolate human 
DNA repair genes, with an emphasis on ionizing 
radiation repair genes. Successful methods adopted 
to date have included transfection complementation 
of genotoxin-sensitive mutants (e.g., ERCC genes, 
XRCCI); approaches in which a functional in vitro 
assay has been used to purify a protein activity, 
followed by amino acid sequencing to allow synthe- 
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sis of degenerate oligonucleotide primers, and identi- 
fication of the corresponding cDNA sequence using 
PCR/library screening (e.g., XPC, PCNA); and by 
virtue of sequence homology to cloned DNA repair 
genes of lower species, typically yeast (e.g., HHR6A, 
HHR6B, HHR23A. HHR23B). A further point was 
the influence of serendipity: the involvement of DNA 
repair genes in other cellular processes has been 
uncovered by others working in different areas of 
enquiry (e.g., XPB and XPD genes identified as part 
of the basal transcription machinery). Positional 
cloning has also been used in the search for ionizing 
radiation repair genes. For example, the XRCCS 
gene was mapped to 2q33-35 by microcell-mediated 
human chromosome transfer followed by 
irradiation-fusion gene transfer (IFGTJ, prior to the 
finding that the gene encoding Ku 80 was defective 
in the corresponding mammalian mutants. This 
speaker also noted the recently determined link be- 
tween mammalian ionizing radiation sensitivity, 
DNA double-strand break rejoining, V(D)J recombi- 
nation and possibly signal transduction brought about 
by the significant discovery that an abundant nuclear 
Ku antigen subunits and the DNA-dependent protein 
kinase catalytic subunit (DNA-PK,,) were defective 
in mammalian ionizing radiation-sensitive mutant cell 
lines (corresponding to human XRCCS and -7 genes). 
A point of note in this regard was the recent cloning 
of a full-length (approx. 15 kb) DNA-PK,, cDNA by 
T. Blunt in the speaker’s laboratory. Transfection of 
this cDNA corrected DNA-PK activity, V(D)J re- 
combination in a transient expression assay, and 
radiosensitivity of V3 Chinese hamster ovary (CHO) 
mutant cells, although the radiosensitivity correction 
was not complete. One explanation offered for the 
latter finding was that the human and endogenous 
CHO proteins might not have the same physical 
configurations. The major recent achievement of the 
cloning of the gene responsible for ataxia-telangiec- 
tasia (AT), ATM, was also discussed. Among the 
increasing number of genes showing homology to 
ATM was the rad3 gene of Schizosaccharomyces 
pombe: a recent finding was that A. Carr from his 
laboratory had identified a second human AT-related 
gene to which the rad3 gene was more closely 
homologous. A final point was the recent dramatic 
increase in cloning of human ionizing radiation re- 
pair genes, with the current list including XRCCI-7, 
ATM, DNA-PK components, human homologs of 
RADSI, -52 and -54 genes of Saccharomyces cere- 
cisiae, and DNA ligases I, III and IV. 
The study of ultraviolet radiation repair genes has 
provided a paradigm for DNA repair. D. Bootsma 
(Erasmus University, The Netherlands) outlined work 
on the xeroderma pigmentosum (XP> complementa- 
tion group B gene (XPB/ ERCC3). which illustrated 
the fact that different mutations in the same gene can 
give rise to diverse clinical manifestations. Such 
conditions might give clues to the biological roles of 
these proteins, for example, the contribution of par- 
ticular mutations to a predisposition to carcinogene- 
sis. For a long time, only one individual with com- 
bined XP/Cockayne syndrome (CS) was known. 
This female manifested severe CS and XP clinical 
features and her fibroblasts had < 5% unscheduled 
DNA synthesis CUDS; a biochemical marker of NER 
function), and a frameshift at amino acid 742 (the 
protein is 782 amino acids in length) due to a 
splicing mutation defect of XPB. This individual 
succumbed to cancer at an early age. More recently, 
two brothers with XP/CS were identified with XPB 
mutations (phenylalanine to serine substitution at 
amino acid 99) and XP clinical and biochemical 
features approximately as severe as the first individ- 
ual, but with very mild CS features. These individu- 
als remain cancer-free at ages 38 and 39. Very 
recently, the first known trichothiodystrophy (TTD) 
individual was found with a mutation (at amino acid 
119) of the XPB protein. Like for CS, no increased 
incidence of cancer has been seen in TTD. This 
speaker also noted that a number of viable mouse 
models for NER have now been created. The list 
includes knockouts of ERCCI. XPA, XPC and CS- 
B, whilst experiments generating mice harbouring 
subtle mutations in other DNA repair genes (e.g., 
XPB, XPD) are in an advanced stage in his labora- 
tory. 
The present status of cloning and mapping the 
XRCC group of ionizing radiation repair genes was 
addressed by L. Thompson (Lawrence Livermore 
National Laboratory, USA). A recent suggestion by 
this speaker was to adopt the ‘XRCC’ nomenclature 
for new human ionizing radiation repair genes which 
are isolated via complementation of rodent mutants. 
The major XRCC mutants, and the chromosomal 
localization of their complementing XRCC genes 
Table 1 
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Major mammalian ionizing radiation sensitive ‘XRCC’ mutants, grouped according to phenotype 
Phenotype Mutant Gene Chromosomal 
localisation 
DNA dsb rejoining- 
deficient 
DNA single-strand break 
rejoining-deficient 
Strand break repair 
‘proficient‘ 
XR-I, Ml0 
xrs5. XRVISB. sxi-3 
V3/SCID 


















was summarised by this speaker, and is reproduced 
in Table 1. Attempted functional complementation of 
the irsSF mutant (XRCC3 gene) with an integrating 
cDNA library had yielded a cDNA which restored 
chromosomal instability to approximately wild-type 
levels; however, X-ray sensitivity correction was 
only around 40%. The XRCC3 cDNA showed par- 
tial primary amino acid sequence homology to other 
genes involved in the ionizing radiation response 
(RAD57 and RAD.51 of S. cerevisiae and the human 
homolog of the latter gene, HsRADSl), including a 
nucleotide binding box. Data were also provided 
regarding a recently characterized mammalian mu- 
tant, UV40, representing the uncloned XRCC9 gene 
based on a unique mutant phenotype. This mutant 
showed broad spectrum genotoxin sensitivity (in- 
cluding 2-fold to ionizing radiation; 4-fold to UV; 
7-fold to ethylmethane sulphonate and 1 l-fold to 
mitomycin Cl, a 4-fold increase in sister chromatid 
exchange. an increased chromosome aberration fre- 
quency, and, despite the UV sensitivity, wild-type 
UDS. Regarding attempts to generate an XRCCI 
knockout mouse, this speaker reported that experi- 
ments were far advanced, but homozygous null mu- 
tants were not yet obtained. 
Experiments characterizing the scid phenotype 
were reported by C. Kirchgessner (Stanford Univer- 
sity, USA). It was previously reported that the scid 
phenotype (e.g., ionizing radiation sensitivity and 
V(DlJ recombination deficiency) was corrected by 
human chromosome 8. Work from several groups, 
including that of this speaker, strongly suggested that 
DNA-PK,, and scid are the same gene; these data 
included complementation of the V(D)J recombina- 
tion deficiency and radiosensitivity of scid cells (and 
cells from the V3 CHO mutant residing in the same 
complementation group) by YACS containing peri- 
centric regions of human chromosome 8, as well as 
restoration of DNA-PK activity by chromosome 8- 
complemented scid/ V3 cells. Mapping the scid lo- 
cus was recently refined to 8p 11.1 -q 11.1. Proof that 
the DNA-PK,, is the gene defective in scid mice 
will require identifying mutations in this gene in scid 
mice: recent cloning of the full-length cDNA for 
DNA-PK,, (see above) will facilitate this. A model 
for the role of DNA-PK in the processing of DNA 
dsbs was also presented, in which, after binding of 
the Ku 80 and 70 subunits to DNA ends, the DNA- 
PK,, is recruited, forming a scaffold bridging the 
DNA gap, with alteration of the local chromatin 
conformation. DNA-PK has been shown to phospho- 
rylate many proteins in vitro, including numerous 
transcription factors, ~53, topoisomerase II and repli- 
cation protein A, although the physiological down- 
stream phosphorylation targets of DNA-PK in this 
major mammalian DNA dsb repair process are yet to 
be defined. That chromatin structure was important 
to the scid phenotype was further addressed: it was 
previously shown that homozygous scid mutant cells, 
defective in DNA dsb rejoining, were not concomi- 
tantly deficient in rejoining non-genomic (transfected 
plasmid) DNA, suggesting that an inability to pro- 
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cess the DNA dsb in its native chromosomal confor- 
mation was an important factor in scid radiosensitiv- 
ity. In investigating this, the sensitivity of scid cells 
to 3-aminobenzamide, an inhibitor of polyADPribo- 
sylation and therefore a modulator of chromatin 
structure, was examined: scid mutant cells were not 
found to be sensitive to this agent. In the discussion 
which followed this presentation, A. Lehmann made 
the comment that further support for the model of 
DNA-PK forming a scaffold structure at the site of 
DNA dsbs was that apart from just its large size, 
DNA-PK interacts with DNA on a wide front, with 
an approx. 100 nucleotide DNA footprint. 
H. Roest (Erasmus University, The Netherlands) 
reported progress in the development of mouse mod- 
els for homologs of the RAD6 gene of S. cererisiae. 
a gene involved in postreplication repair. RAD6 
mutants have a complex phenotype, with sensitivity 
to many genotoxins, including UV- and ionizing- 
radiation. RAD6 is duplicated in mammals, and both 
genes are functionally homologous to the Xcereuisiae 
gene as shown by their ability to correct, to a large 
extent, the UV-sensitivity of a rud6 null-mutation. 
These mammalian genes are, however, not capable 
of correcting a sporulation defect in this yeast strain. 
The generation of knockout mice for the MR6B 
gene, one of the mouse homologs of RAD6, was 
presented. Fibroblasts isolated from homozygous 
mutant embryos did not show increased sensitivity to 
UV- or ionizing- radiation when compared with 
wild-type embryonal fibroblasts. An interesting fea- 
ture was observed relating to the sporulation defect 
in some yeast rad6 mutants: homozygous mutant 
males showed a clear defect in spermatogenesis, 
whereas female germ cell development was normal. 
The different categories of DNA dsb repair path- 
ways were reviewed by M. Resnick (Research Tri- 
angle Park, USA), with an emphasis on recombina- 
tional DNA dsb rejoining in S. cereuisiae. A number 
of models exist for the latter process, with common 
features including strand invasion, exonuclease 
degradation of (one of) the involved DNA strands, 
and DNA synthesis. This speaker described a recent 
innovation developed in his laboratory: TAR (trans- 
formation associated recombination) cloning. This 
procedure was developed in response to the common 
problem that YACs are often rearranged. Early data 
with this approach showed a high efficiency of re- 
covery of non-chimeric human DNA, with implica- 
tions for areas such as positional cloning by im- 
proved manipulation of large genomic fragments. 
Xenupus (frog) oocytes have been used by P. 
Pfeiffer (University of Koln, Germany) and col- 
leagues to study DNA dsb rejoining after restriction 
enzyme-induced DNA dsbs in substrate plasmids. 
Such systems have a number of important advan- 
tages, including the fact that DNA can be injected 
directly into the nucleus (which can abrogate trans- 
fection artefacts previously described for mammalian 
cells), and because circular plasmid DNA is not 
replicated in oocytes. immediate- as well as end- 
products of repair can be readily isolated for analy- 
sis. The systems are advocated as attractive for the 
study of non-homologous DNA end-joining, and ex- 
periments are in progress to fractionate the active 
extracts in an attempt to delineate the active compo- 
nents. An initial impression was that such systems 
were also promising for the study of ionizing radia- 
tion-induced DNA dsbs. 
A number of mammalian genes have now been 
isolated by virtue of their homology with DNA 
repair genes of lower species. J.-M. Buerstedde 
(Base1 Institute of Immunology, Switzerland) re- 
viewed progress with the identification and charac- 
terization of eukaryotic homologs of the RAD52 
epistasis group of S. cerecisiae, genes involved in 
homologous DNA dsb recombinational repair. Genes 
structurally homologous to RAD51, -52 and -54 
have been cloned from higher species, indicating 
conservation of this repair pathway during eukary- 
otic evolution. In work from a number of laborato- 
ries, most of the genes from S. pombe, chicken, 
mouse and human corresponding to these three RAD 
genes have now been identified. Consistent with 
their putative roles in recombination in mammals, 
the mammalian genes are expressed at relatively 
higher levels in lymphoid and gonadal tissues. With 
respect to the functional significance of the described 
structural homologies, to date, no complete func- 
tional complementation of yeast mutants has been 
reported with these genes, although some partial 
complementation has been observed (e.g., the corre- 
sponding human genes have partially complemented 
MMS sensitivity of RADSI and R4D54 (see below) 
mutants and the mating-type switching defect in an 
S. pombe md22 mutant - the rad22 gene of S. 
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pombe being a structural homolog of S. cerecisiae 
RAD.52). R. Kanaar (Erasmus University. The 
Netherlands) reported the cloning and analysis of a 
human gene structurally homologous to the RAD54 
gene of S. cerwisiae. Degenerate oligonucleotide 
primers based on conserved regions of RAD54 and 
an S. pombe RAD54 equivalent, rhp54, were used to 
PCR-amplify from a chicken cDNA library a frag- 
ment subsequently used to retrieve clones from a 
human cDNA library. The human gene had an open 
reading frame of 2241 bps, and contained conserved 
structural motifs placing it in the SNF2/SW 12 fam- 
ily of putative DNA helicases. The mRNA of the 
mouse homolog of RAD54 was found to be elevated 
in organs of lymphoid and germ cell development. 
An exciting recent development was the report of the 
viability of embryonic stem cells with targeted ho- 
mozygous deletions of the mouse RAD54 homolog, 
constructed in the same laboratory by J. Essers. 
C. Lawrence (University of Rochester, USA) 
reported on work concerning the mutagenic potential 
of certain DNA lesions as a result of processing by 
repair systems which deal with such lesions during 
replication. Data were presented that the mutagenic 
effect of T-T cyclobutane dimers is mainly deter- 
mined by the polymerase that is used in the repair 
process. There appears to be a DNA-polymerase-im- 
posed preference to insert a purine, especially an 
adenine opposite the lesion (‘A’-rule). The S. cere- 
risiae gene, REV3, encodes a non-essential, putative 
polymerase that is involved in translesion synthesis 
after UV radiation. REV3 was shown to interact with 
REV7 and, with both proteins present in a complex, 
is capable of bypassing T-T dimers in vitro. Com- 
puter database searches using REV1 and REV3 iden- 
tified human expressed sequence tags with a homol- 
ogy of 31% and 45%, respectively. At the same 
symposium, M. Goodman (University of Southern 
California, USA) reported on the lesion bypass abil- 
ity of different polymerases and the effect of purified 
proteins like RecA, VmuD and VmuC in an in vitro 
lesion bypass system. This system consists of a 27 
nucleotide single-strand template with a T-T dimer 
and a 15-mer primer. 
The cellular phenomenon of radioresistant DNA 
synthesis (RDS) has long been associated with the 
ionizing radiation sensitive ataxia telangiectasia and 
related disorders, and has also been observed in 
‘AT-like’ mutant rodent cell lines. Using chromo- 
some transfer techniques, M. Zdzienicka (Leiden 
University, The Netherlands), found that chromo- 
some 4q was able to complement the RDS defect in 
a CHO ionizing radiation-sensitive mutant. In this 
case, RDS was uncoupled from radiation sensitivity 
(the latter not being complemented), suggesting the 
mutant may be defective in a gene involved in 
mammalian DNA replication control. 
3. Heterogeneity of DNA repair 
Intragenomic heterogeneity of DNA repair in 
mammalian systems has been recognised for some 
time. Preferential repair of a number of different 
lesion types has been described for many active 
genes. The most extensively studied lesions are UV 
photoproducts, particularly cyclobutane pyrimidine 
dimers (CPDs). In separate presentations, L. Mul- 
lenders and A. van Zeeland (both of Leiden Univer- 
sity, The Netherlands) addressed this topic. NER has 
been the paradigm for the elaboration of the concept 
of preferential repair. Two subtypes of NER have 
been described: RNA pol II transcription-coupled 
NER (TCR; a relatively rapid process), and the 
slower NER restricted to the non-transcribed strands 
of active genes and the remainder of the genome, 
although for CPDs, the non-transcribed strand of 
active genes is still repaired, in general, faster than 
the remainder of the genome. The early methods, 
which powerfully defined the concept of heterogene- 
ity of repair, had the relative disadvantage that repair 
could only be assessed by Southern analysis of large 
DNA fragments (of the order of > 20 kb). More 
recent use of antibodies against specific lesions al- 
lows repair to be evaluated in much smaller frag- 
ments. using either Southern blot analysis or PCR. 
Further advantages of PCR for this use are that 
changes can be detected in situ, and at more physio- 
logically relevant doses of the genotoxin in question. 
In the case of XP complementation group C, there 
is a defect in the repair of UV-photolesions (and 
some other lesions, such as crosslinks) in the genome 
overall, but no defect in transcription-coupled repair. 
The XP-C defect contrasts with a specific transcrip- 
tion-coupled repair defect in cells from CS patients, 
who are not cancer-prone: XP-C is therefore an 
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important XP subgroup for carcinogenesis studies. 
These differences were also referred to by D. 
Bootsma in a previous session, who emphasised that 
it appears that defects in the process of repair in 
non-transcribed sequences could be responsible for 
carcinogenesis, and that mouse models of defects in 
these particular genes may be useful in studying this. 
Many systems, ranging from E. coli to mammals, 
have now been tested for the presence of DNA 
strand-specific and preferential repair of many differ- 
ent genotoxins (e.g., UV-photoproducts, alkylating 
and cross-linking agents and ionizing radiation). No 
cases of strand-specific repair have yet been reported 
in the absence of preferential repair of the lesion in 
question. Factors affecting strand-specificity and 
preferential repair include the genotoxin used (e.g., 
N-(deoxyguanosin-8-yl)-2-aminoflourene (dG-C8- 
AF) repair does not show strand specificity, although 
these lesions are thought to be processed by the same 
pathway as UV-photolesions), the organism and de- 
velopmental stage (e.g., Drosophila embryonic cells 
show neither strand-specificity nor preferential re- 
pair) and the dose of genotoxin (e.g., preferential 
repair of CPDs is dose-dependent over the range of 
approx. lo-30J/m’: higher doses are believed to 
abolish preferential repair in active genes through 
prolonged inhibition of both transcription initiation 
and elongation). Some questions for the future in- 
clude determining the effect on repair of acetyla- 
tion/methylation and the relationship of the gene 
under study to the nuclear matrix. 
P. Cooper (University of Berkeley, USA), ad- 
dressed the topic of transcription-coupled repair of 
ionizing radiation induced DNA base damage in 
XP-G and CS human cells. It was previously shown 
that ionizing radiation can influence transcription 
initiation, that TCR of ionizing radiation induced 
DNA damage exists in human cells, and that the 
process was defective in cells from CS individuals. 
The present work extended these findings to the 
study of induction and repair of ionizing radiation 
induced thymine glycols (a form of oxidative dam- 
age) in cells from another NER defective condition, 
XP-G. Thymine glycols were detected by specific 
antibodies in an ELISA assay. XP-G is a rare XP 
complementation group, with individuals showing a 
diverse clinical spectrum. XP-G cells (the XP3BR 
fibroblast cell line) were first shown to be ionizing 
radiation sensitive in 1980 by C. Arlett: their sensi- 
tivity is approx. 2-fold compared with wild-type 
fibroblasts. This cell line was also found to have 
slightly higher sensitivity to high linear energy trans- 
fer (LET) radiation than wild-type. The ionizing 
radiation-sensitive XP-G cell lines were shown to 
harbour a defect in the transcription-coupled repair 
of thymine glycols. The thymine glycol repair defect 
was found to be associated with some, but not all. 
XP-G cell lines. It was suggested that the XPG 
protein may have a function additional to its role in 
NER: its involvement in a possible process coupling 
transcription to oxidative damage repair. 
Biophysical studies addressing the effects of chro- 
matin on radiosensitivity were presented by S. Chiu 
(Case Western University, USA) and E. Woudstra 
(Groningen, The Netherlands). The former speaker 
addressed DNA-protein crosslink (DPC) formation 
after ionizing radiation. Characteristics of these het- 
erogeneous lesions include a yield of approx. 3% of 
the number of DNA single-strand breaks induced by 
low-LET radiation (one estimate is 34 
DPCs/Gy/cell) and an increase in their production 
under hypoxia (factors of 1.4-2.3-fold have been 
found). Evidence was presented that histones are 
rarely involved in DPCs, with nuclear matrix pro- 
teins being the usual DPC protein substrate. It was 
suggested that the repair of DPCs may be by differ- 
ent pathways than those used for DNA dsb repair. 
This suggestion was based on the fact that there was 
no detectable DPC repair defect in the XR-I or .xrsh 
mutants (XRCC3 and XRCC.5 genes, respectively: 
Table 1) in comparison to wild-type. However, lack 
of involvement of other DNA dsb repair genes in 
DPC repair was not excluded in these studies. The 
latter speaker reported on studies which used mam- 
malian cell lines of differing radiosensitivity and 
differences in the induction of DNA dsbs, but in 
which DNA dsb repair was equivalent. Such lines 
were suggested to be good candidates for harbouring 
differences in chromatin structure affecting radiosen- 
sitivity. In an assay based on chromatin unwinding 
(‘halo’ assay), the radiosensitive HX142 neuroblas- 
toma cell line showed greater post-irradiation un- 
winding. Further studies identified the lack of two 
proteins (of 49.5 and 34.8 kDa) in the radiosensitive 
HX142 cell line. It was suggested that these proteins 
were candidate DNA-matrix attachment region 
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(MAR) proteins, based on the hypothesis that cell 
lines with an unstable MAR cannot restrict DNA 
dsbs to one DNA loop-matrix unit, resulting in greater 
chromatin unwinding. Attempts were in progress to 
identify the proteins concerned. 
N. Oleinick (Case Western Reserve University, 
USA) discussed the role of DNA organization in 
eukaryotic nuclei in relation to hypersensitivity of 
certain regions for damage. The nuclear matrix is 
responsible for the formation of chromosomal loops 
of 50- 100 kbp. These loops are formed through 
anchorage of matrix-attachment DNA sequences to 
the nuclear matrix. DNA in these loops is associated 
with fewer histones as a result of high transcription 
activity, replication and some types of repair. This 
renders these loops hypersensitive to, for example, 
ionizing radiation. In vitro formation of these loop- 
containing matrices is achieved by creating an envi- 
ronment with increasing ionic strengths to release 
histones and other proteins. 
P. Cook (University of Oxford, UK) also pre- 
sented data that subscribes the theory of specific, 
active foci in the DNA-matrix. Active polymerases 
involved in replication, transcription as well as 
DNA-repair are concentrated in about 2500 foci in 
the nucleus of HeLa cells. An interesting observation 
was that foci involved in DNA repair/replication are 
not used for transcription and vice versa. 
4. Molecular and genetic aspects of cancer devel- 
opment 
Using illustrative data mainly obtained from colon 
cancer cell lines, E. Stanbridge (University of Cali- 
fornia at Irvine, USA), presented an overview of 
some of the genetics and molecular mechanisms of 
carcinogenesis. According to the model previously 
proposed by Loeb, a ‘mutator’ genomic instability 
phenotype can occur as a result of dysfunction of 
genes involved in fundamental processes such as 
mismatch or excision repair, DNA replication or 
chromosomal segregation. Tumor progression can 
thereafter ensue as a result of mutations in a sec- 
ondary level of genes (e.g., ras, ~53). Studies such 
as those performed with colon cancer cell lines have 
supported this hypothesis: genomic instability, as- 
sessed at various microsatellite loci. was reversed by 
somatic cell fusion, transfer of the relevant whole 
chromosome containing the mismatch repair locus 
absent in the cell line, or expression of the relevant 
cDNA. Such results showed that the condition was 
recessive. An important result was that the malignant 
phenotype was still maintained, suggested to be not 
unexpected because of the multiple genes involved 
in tumorigenesis. Other studies with the SW480 
colon cancer cell line used microcell-mediated hu- 
man chromosome transfer to examine the influence 
of restoration of wild-type copies of genes which 
were mutated in that cell line, with the endpoint 
being the effect on tumorigenicity. Sequential trans- 
fer of chromosome 18 (containing the DCC wild- 
type gene) and chromosome 5 (containing the APC 
wild-type gene) reduced tumorigenicity by approx. 
50% and over 90%, respectively, whilst transfer of 
chromosome 17 (containing wild-type ~53) resulted 
in tumour regression by an apoptotic mechanism. 
Whilst other genes on these chromosomes could 
clearly be affecting the results, transfer of irrelevant 
chromosomes as controls had no effect on tumori- 
genicity, and the chromosome 17 result was con- 
firmed by cDNA expression of wild-type ~53. Other 
studies showed that expression of activated ras had 
no observable tumorigenic effect on normal human 
cells, but resulted in phenotypic progression in trans- 
formed cell lines. 
H. de The (Hopital Saint Louis, Paris, France), 
overviewed some leukemo- and lymphoma-genesis 
mechanisms resulting from different functional 
classes of proteins derived from transforming genes 
located at translocation breakpoints. Molecular tech- 
niques have proved very powerful in dissecting the 
relevant mechanisms. Three broad categories could 
be discerned. The first involves insertion of a pro- 
moter which deregulates the expression of an onco- 
gene. An example is the classical t(8:14) transloca- 
tion, where the strong promoter from the im- 
munoglobulin H or T-cell receptor (Y loci on chro- 
mosome 14 are translocated to c-Myc on chromo- 
some 8q. The second category is the formation of a 
chimeric gene by fusion of (part of> one protein with 
another. Typically, the two proteins are involved in 
either signalling cascade pathways or are transcrip- 
tion factors, and the fusion protein acts in both 
pathways. An example is the BCR-ABL transloca- 
tion. A third mechanism involves fusion between a 
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kinase domain and a nuclear protein, resulting in 
inappropriate protein phosphorylation within the nu- 
cleus. An example is the ALK-NPM fusion in non- 
Hodgkins lymphoma. Medical uses of studying these 
proteins include the diagnosis and assessment of 
minimal residual disease (using RT-PCR) after 
chemotherapy or radiotherapy for leukemias and 
lymphomas, and the potential for developing 
tumour-specific antibodies. 
Genetic disorders conferring specific risk for can- 
cer development, especially after ionizing radiation 
exposure, were addressed by R. Cox (Didcot, UK). 
Second malignant (and occasionally benign) neo- 
plasms occur at very low rates after therapeutic 
radiation for cancer at most sites. However, in some 
situations, the risk is greater. In sporadic retinoblas- 
toma cases, the risk of later developing osteosarcoma 
within the irradiated field is approx. 2-fold increased, 
soft tissue sarcoma > 2-fold increased and there is 
an increased risk of tumors of the brain. meninges 
and melanoma. This is presumably the result of the 
germline inactivation of one Rb allele in these indi- 
viduals, and radiation-induced inactivation of the 
second allele. Individuals with Gorlin’s (basal cell 
nevus) syndrome have a hugely increased risk of 
ionizing radiation-induced cancer, first noted when 
patients received radiation therapy for a rare type of 
cerebellar tumor to which they are predisposed 
(medulloblastomal. The sensitivity to tumour induc- 
tion is in the form of multiple (often thousands) of 
basal cell carcinomas (and to a lesser degree, squa- 
mous cell carcinomas) on the irradiated skin. and an 
increase in pre-pubertal ovarian fibromas and fi- 
brosarcomas in females. A point of note regarding 
the ovarian tumors appears to be a greatly reduced 
latency between irradiation and tumor formation, 
implying that the involved gene is probably a tumour 
suppressor gene. This speaker also indicated that in 
normal individuals, the breast is an organ with a 
particular increased post-irradiation tumour forma- 
tion risk. For example, a 13.5fold increase in pre- 
menopausal breast cancer has been reported in A- 
bomb survivors. This is topical in view of previous 
suggestions that AT heterozygotes may be at in- 
creased tumor risk from screening mammography, a 
testable hypothesis now the ATM gene is cloned. 
The effect of ~53 on ionizing radiation carcinogene- 
sis was also addressed in this presentation. Previous 
work showed that ~53 homozygous null mice are 
greatly predisposed to spontaneous tumor formation. 
After ionizing radiation, no increased tumor risk was 
seen in the homozygous null animals, presumably 
because of the high background cancer rate. Mice 
heterozygous for ~53, analogous to the human condi- 
tion, Li-Fraumeni syndrome (in which individuals 
harbour a germline inactivating mutation in one ~53 
allele) had a greatly increased post-ionizing radiation 
cancer incidence, with tumor levels intermediate be- 
tween unirradiated or irradiated homozygous null 
animals and irradiated wild-type controls. Another 
point addressed by this speaker was the ,Eker rat: 
heterozygous rodents are at increased risk for ioniz- 
ing radiation carcinogenesis and as such have proved 
a useful model system. The relevant gene had been 
localised to rat chromosome 1Oq by positional 
cloning: recently, the TSC2 (tuberous sclerosis 2) 
gene was cloned, revealing that it was the human 
equivalent of the Eker gene. As such, individuals 
with TX2 mutations might also be expected to have 
enhanced tumorigenic radiosensitivity. 
5. Miscellaneous 
Regarding ionizing radiation mutagenesis, J. 
Thacker (Didcot, UK), identified three fundamental 
issues: the molecular spectrum of mutations, identi- 
fying which of these are important to carcinogenesis 
and hereditary diseases, and addressing what might 
happen to individuals with a compromised ability to 
process the mutations. Much current research is fo- 
cussed on the first of these issues. This speaker 
stressed the importance of the systems used to exam- 
ine mutations, as different systems (such as different 
species, different reporter genes) may give very dif- 
ferent results. For example, the HPRT and APRT 
genes of hamster cells are commonly used for muta- 
tional analysis. Advantages of the former is its large 
size (and therefore suitability for analysing large 
mutations characteristic of ionizing radiation-induced 
mutations), and both genes are non-essential and in 
single copy. However, when post irradiation muta- 
tional spectra are analysed, there is a marked differ- 
ence between the two genes, with the former show- 
ing many large mutations (deletions/rearrange- 
ments) and the latter a much greater incidence of 
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point mutations. A possible explanation is that there 
might be an essential gene adjacent to APRT, dele- 
tion or rearrangement of which would destroy the 
APRT reporter function. The latter has experimental 
support in that in systems with multiple APRT copies. 
many more mutants (and mutants with larger muta- 
tions) are recovered. In terms of the more common 
large deletions/rearrangements seen after ionizing 
radiation exposure, recent work from the speaker’s 
laboratory has shown that when regions flanking 
such mutations were sequenced, direct DNA repeats 
were commonly found on either side. There has also 
been the recognition that ionizing radiation. as op- 
posed to other mutagens, causes a greater incidence 
of so-called ‘unconventional’ mutational events, such 
as delayed or co-incident mutations or hereditable 
genetic instability. Possible explanations suggested 
for these data included alterations in chromatin. mo- 
bilization of transposable elements, persistent lesions 
or induction of an altered metabolic state (altered 
gene expression). Of topical interest was that AT 
shows, in general. a spontaneous increase in such 
unconventional mutational events. 
G. McKenna (University of Pennsylvania, USA) 
reviewed the normal controls of the eukaryotic cell 
cycle before addressing the association between ion- 
izing radiation and the cell cycle. Some notable 
themes have emerged in the latter area over the last 
few years. One prominent theme is that of cell cycle 
checkpoints. feedback controls initially described in 
S. cerevisiae in response to ionizing radiation, which 
halt cell cycle damage in response to DNA damage, 
presumably to allow time for repair. Determining the 
mechanisms whereby the presumed signal arising 
from damaged DNA is transduced to the cell cycle 
regulators is of major interest. Whilst most is known 
about yeast checkpoints, another recent finding is 
that many of the genes regulating the yeast cell cycle 
and involved in checkpoint controls are conserved in 
mammals. A number of proteins critical to the cellu- 
lar response to ionizing radiation damage also regu- 
late the cell cycle checkpoints. Notable examples are 
ATM, p.53 and pl6/CIPl. Determining the exact 
roles such proteins play in cell cycle regulation and 
how they interact with the intrinsic cell cycle ma- 
chinery is an area of intense recent interest. 
R. Haynes (York University. Toronto, Canada) 
reviewed the history of the field of DNA repair. This 
report cannot do justice to this seminal lecture, but 
only touch on a few of the major points raised. The 
concept of DNA repair originated in the field of 
radiobiology/photobiology: the present meeting was 
held precisely 30 years after the first DNA repair 
conference, in the University of Chicago, 1965, one 
year after Setlow and Carrier and Boyce and 
Howard-Flanders independently described excision 
repair of pyrimidine dimers. Interestingly, the major- 
ity of early radiation research was initially concen- 
trated on cellular ionizing radiation repair. With the 
discovery of the pyrimidine dimer photolesion and 
the development of assays for its study, many work- 
ers moved to UV repair. an area which developed 
into the active field it is today. The comment was 
made that many of the molecular tools developed in 
the study of UV radiation and its effects are now 
being applied to the study of ionizing radiation dam- 
age and repair, with numerous recent advances (as 
also addressed by a number of other speakers at this 
congress). Studies in the latter half of the 1960s with 
E. coli by Witkin were stated to have been instrt- 
mental in developing the major new concepts that 
repair was linked to mutation, and that mutation was 
not a physical process (as held in early studies by 
workers as prominent as Max Delbriickl but a bio- 
chemical process. The description by Cleaver in 
1968 that XP was a human condition resulting from 
defective DNA repair was a landmark in demonstrat- 
ing the (potential) importance of the developing field 
to human health. Two other cellular repair functions 
of major evolutionary significance were identified as 
the proofreading function after DNA replication and 
mismatch repair, the latter perhaps being the major 
speciation barrier. 
6. Closing statements 
Molecular genetic approaches are now yielding 
many new genes involved in the cellular response to 
ionizing radiation damage. It is expected that the 
number of new genes reported will increase substan- 
tially before the next radiation research congress. 
The next phase will be to determine the biologic 
roles of the protein products of the genes, arguably a 
more difficult task. Potential contributions of such 
work to human health are great, however, and in- 
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elude, as for the study of UV damage processing, a 
greater understanding of the mechanism of ionizing 
radiation-induced carcinogenesis. An additional and 
major aspect of the potential of molecular radiation 
biology research is for a contribution to the manage- 
ment of individuals with cancer. For example, if one 
or a few genes prove to be involved in the majority 
of individuals with enhanced radiotherapy reactions, 
this could open the way for pre-radiotherapy genetic 
screening, whilst a greater understanding of radiation 
response genes could translate to novel approaches 
to the treatment of cancer with ionizing radiation. 
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